About Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL) is a type of cancer which affects the cells of the lymphatic system known as white blood cells. It typically occurs when lymphocytes, a type of white blood cell found in the lymph nodes, grow and multiply uncontrollably, causing swelling of the lymph nodes.
​
There are many different types of lymphoma however, the two most common types are Hodgkin Lymphoma and Non-Hodgkin Lymphoma.
​
Over 14,000 people are diagnosed with Non-Hodgkin Lymphoma each year in the UK with around 4,800 attributable deaths making it the fifth most common cancer and the most common blood cancer.
​
The exact cause of Non-Hodgkin Lymphoma is currently unknown. It it thought to to be more common in people with weakened immune systems.
​
As a charity we are committed to making a difference to the lives of those affected by this terrible disease. Since 2020 we have awarded over £21,000 in financial grants to medical researchers at The University of Southampton for the research and development into Non-Hodgkin Lymphoma.
​
​
A common symptom of lymphoma is swollen lymph nodes, in the neck , groin, collarbone, armpit or other parts of the body
Our Mission
The Karen Ingram Foundation aims to raise awareness and improve survival rates into the blood cancer Non-Hodgkin Lymphoma
Our Vision
Together with the University of Southampton, we are providing financial grants for the research and development of Non-Hodgkin Lymphoma.
​
Utilising a revolutionary new treatment called "immunotherapy" , the clinical cancer trials look to harness the power of the bodies immune system to detect and ultimately destroy lymphoma cancer cells.
​
The project is led by Professor Peter Johnson, Lymphoma Expert.